Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by obliteration of alveolar architecture, resulting in declining lung function and ultimately death. Pathogenic mechanisms remain unclear but involve a concomitant accumulation of scar tissue together with myofibroblasts activation. Microparticles (MPs) have been investigated in several human lung diseases as possible pathogenic elements, prognosis markers and therapeutic targets. We postulated that levels and cellular origins of circulating MPs might serve as biomarkers in IPF patients and/or as active players of fibrogenesis. Flow cytometry analysis showed a higher level of Annexin-V positive endothelial and platelet MPs in 41 IPF patients compared to 22 healthy volunteers. Moreover, in IPF patients with a low diffusing capacity of the lung for carbon monoxide (DLCO<40%), endothelial MPs (EMPs) were found significantly higher compared to those with DLCO>40% (p = 0.02). We then used EMPs isolated from endothelial progenitor cells (ECFCs) extracted from IPF patients or controls to modulate normal human lung fibroblast (NHLF) properties. We showed that EMPs did not modify proliferation, collagen deposition and myofibroblast transdifferentiation. However, EMPs from IPF patients stimulated migration capacity of NHLF. We hypothesized that this effect could result from EMPs fibrinolytic properties and found indeed higher plasminogen activation potential in total circulating MPs and ECFCs derived MPs issued from IPF patients compared to those isolated from healthy controls MPs. Our study showed that IPF is associated with an increased level of EMPs in the most severe patients, highlighting an active process of endothelial activation in the latter. Endothelial microparticles might contribute to the lung fibroblast invasion mediated, at least in part, by a fibrinolytic activity.
This work was supported by grants of Chancellerie des Universities (Legs Poix) and Coeny-maeva charitable foundation.
Nour C. Bacha is supported by a grant from « Fonds de dotation pour la Recherche en Santé Respiratoire ».
We thank the technicians and engineers of hematology department of Georges Pompidou hospital, in particular Sebastien Bertil, Alexandre Kisaoglou, Florence Desvard, Nadège Ochat and Yann Burnel.
Compliance with Ethical Standards
Declaration of Interest
Authors declare no conflict of interest related to this work.
- 1.Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., et al. (2015). An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. American Journal of Respiratory and Critical Care Medicine, 192(2), e3–19.CrossRefPubMedGoogle Scholar
- 3.Toshner, M., Voswinckel, R., Southwood, M., Al-Lamki, R., Howard, L. S. G., Marchesan, D., et al. (2009). Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine, 180(8), 780–787.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Amabile, N., Heiss, C., Real, W. M., Minasi, P., McGlothlin, D., Rame, E. J., et al. (2008). Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine, 177(11), 1268–1275.CrossRefPubMedGoogle Scholar
- 9.Iversen, L. V., Ullman, S., Østergaard, O., Nielsen, C. T., Halberg, P., Karlsmark, T., et al. (2015). Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis. BMC Musculoskeletal Disorders, 16, 191.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Empana, J.-P., Boulanger, C. M., Tafflet, M., Renard, J. M., Leroyer, A. S., Varenne, O., et al. (2015). Microparticles and sudden cardiac death due to coronary occlusion. The TIDE (Thrombus and Inflammation in Sudden Death) study. European Heart Journal. Acute Cardiovascular Care, 4(1), 28–36.CrossRefPubMedGoogle Scholar
- 17.Poncelet, P., Robert, S., Bouriche, T., Bez, J., Lacroix, R., & Dignat-George, F. (2016). Standardized counting of circulating platelet microparticles using currently available flow cytometers and scatter-based triggering: forward or side scatter? Cytometry Part A: the Journal of the International Society for Analytical Cytology, 89(2), 148–158.CrossRefGoogle Scholar
- 19.Silvestre, J. S., Smadja, D. M., & Levy, B. I. (2013). Postisch-emic revascularization: from cellular and molecular mechanisms to clinical applications. Physiological Reviews, 93, 1743–1802.Google Scholar
- 21.Smadja, D. M., Bièche, I., Silvestre, J.-S., Germain, S., Cornet, A., Laurendeau, I., et al. (2008). Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(12), 2137–2143.CrossRefPubMedGoogle Scholar
- 22.Smadja, D. M., Levy, M., Huang, L., Rossi, E., Blandinières, A., Israel-Biet, D., et al. (2015). Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells. Thrombosis and Haemostasis, 114(4), 735–747.PubMedGoogle Scholar
- 29.Scotton, C. J., Krupiczojc, M. A., Königshoff, M., Mercer, P. F., Lee, Y. C. G., Kaminski, N., et al. (2009). Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. The Journal of Clinical Investigation, 119(9), 2550–2563.PubMedPubMedCentralGoogle Scholar
- 30.Cointe, S., Judicone, C., Robert, S., Mooberry, M. J., Poncelet, P., Wauben, M., et al. (2017). Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop. Journal of Thrombosis and Haemostasis, 15(1), 187–193.CrossRefPubMedGoogle Scholar
- 32.Ratajczak, J., Kucia, M., Mierzejewska, K., Marlicz, W., Pietrzkowski, Z., Wojakowski, W., et al. (2013). Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133 + cells–implications for stem cell therapies in regenerative medicine. Stem Cells and Development, 22(3), 422–430.CrossRefPubMedGoogle Scholar
- 35.Doeuvre, L., & Angles-Cano, E. (2009). Cell-derived microparticles unveil their fibrinolytic and proteolytic function. Medical Science, 25(1), 37–44.Google Scholar
- 39.Ruehl, M., Muche, M., Freise, C., Erben, U., Neumann, U., Schuppan, D., et al. (2011). Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42. Fibrogenesis Tissue Repair, 4(1), 1.CrossRefPubMedPubMedCentralGoogle Scholar
- 46.Simoncini, S., Chateau, A.-L., Robert, S., Todorova, D., Yzydorzick, C., Lacroix, R., et al. (2017). Biogenesis of pro-senescent microparticles by endothelial colony forming cells from premature neonates is driven by SIRT1-dependent epigenetic regulation of MKK6. Scientific Reports, 7(1), 8277.CrossRefPubMedPubMedCentralGoogle Scholar